{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = 4-Amino-3-(4-fluorophenyl)butanoic acid
| image = 4-Fluorophenibut.svg
| width = 

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = [[Oral administration|Oral]]

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 

<!-- Identifiers -->
| CAS_number_Ref = 
| CAS_number = 52237-19-1
| CAS_supplemental = 
| class = 
| ATC_prefix = 
| ATC_suffix = 
| ATC_supplemental = 
| PubChem = 103611
| IUPHAR_ligand = 
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 93547
| UNII = 
| KEGG = 
| ChEBI = 
| ChEMBL = 
| synonyms = CGP-11130; β-(4-Fluorophenyl)-γ-aminobutyric acid; β-(4-Fluorophenyl)-GABA; Baflofen; Fluorophenibut; F-Phenibut; Fluoribut

<!--Chemical data-->
| C=10 | H=12 | F=1 | N=1 | O=2
| SMILES = C1=CC(=CC=C1C(CC(=O)O)CN)F
| StdInChI_Ref = 
| StdInChI = 1S/C10H12FNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)
| StdInChIKey_Ref = 
| StdInChIKey = QWHXHLDNSXLAPX-UHFFFAOYSA-N
}}

'''4-Fluorophenibut''' (developmental code name '''CGP-11130'''; also known as '''β-(4-fluorophenyl)-γ-aminobutyric acid''' or '''β-(4-fluorophenyl)-GABA''') is a [[GABAB receptor|GABA<sub>B</sub> receptor]] [[agonist]] which was never marketed.<ref name="pmid6297646">{{cite journal | vauthors = Bowery NG, Hill DR, Hudson AL | title = Characteristics of GABAB receptor binding sites on rat whole brain synaptic membranes | journal = Br. J. Pharmacol. | volume = 78 | issue = 1 | pages = 191–206 | year = 1983 | pmid = 6297646 | pmc = 2044790 | doi = | url = }}</ref> It is [[binding selectivity|selective]] for the GABA<sub>B</sub> receptor over the [[GABAA receptor|GABA<sub>A</sub> receptor]] ([[IC50|IC<sub>50</sub>]] = 1.70&nbsp;µM and > 100&nbsp;µM, respectively).<ref name="pmid6297646" /> The drug is a [[GABA analogue]] and is closely related to [[baclofen]] (β-(4-chlorophenyl)-GABA), [[tolibut]] (β-(4-methylphenyl)-GABA), and [[phenibut]] (β-phenyl-GABA).<ref name="pmid6297646" /> It is less potent as a GABA<sub>B</sub> receptor agonist than baclofen but more potent than phenibut.<ref name="pmid6297646" />

==References==
{{Reflist|2}}


{{GABA receptor modulators}}

{{DEFAULTSORT:Fluorophenibut, 4-}}
[[Category:Amines]]
[[Category:Carboxylic acids]]
[[Category:Experimental drugs]]
[[Category:Fluoroarenes]]
[[Category:GABA analogues]]
[[Category:GABAB receptor agonists]]


{{Nervous-system-drug-stub}}